Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 07-2015 | 07-2014 | 07-2013 | 07-2012 | 07-2011 | |
| Operating Expenses | 2,822 | 443 | 433 | 548 | 1,013 |
| Operating Income | -2,822 | -443 | -433 | -548 | -1,013 |
| Other Income | -75 | -7,817 | 57 | -441 | -23 |
| Pre-tax Income | -2,897 | -8,261 | -376 | -989 | -1,035 |
| Net Income Continuous | -2,897 | -8,261 | -376 | -989 | -1,035 |
| Net Income | $-2,897 | $-8,261 | $-376 | $-989 | $-1,035 |
| EPS Basic Total Ops | -1,886.44 | -6,334.42 | -449.45 | -901.13 | -1,370.95 |
| EPS Basic Continuous Ops | -1,760.66 | -6,522.92 | -296.78 | -783.47 | -1,476.35 |
| EPS Diluted Total Ops | -1,886.44 | -6,334.42 | -449.45 | -901.13 | -1,370.95 |
| EPS Diluted Continuous Ops | -1,760.66 | -6,522.92 | -296.78 | -783.47 | -1,476.35 |
| EBITDA(a) | $-2,822 | $-442 | $-432 | $-547 | $-1,010 |